Tweets
#EULAR2024 POS1325 Childhood onset #lupus is often more severe with high mortality rate. Similar to findings in adults, 2 cSLE patients with refractory disease including failure to CyC, RTX & PLEX responded to CD19 CAR T cells with similar short term safety profile @RheumNow https://t.co/YD2arjxcso
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 10 months ago
lanalumab (anti-baff) LTE 1/3 to 1/2 LLDAS/DORIS remission at 52 wks, reduction autoabs etc - looking very promising @RheumNow #EULAR2024
Peter Nash @drpnash ( View Tweet )
1 year 10 months ago
Frank Buttgereit discusses potential reason for ceiling effect in RA and questions why we don’t use more combination therapy in RA (including low dose of of GC), using the example of Hypertension guidelines
Is long term low dose GC in RA really a desirable option?
@RheumNow… https://t.co/Nc7lldN7Nd https://t.co/63K96uuhKG
Links:
Aurelie Najm @AurelieRheumo ( View Tweet )
1 year 10 months ago
Tips to help in self-management. Procrastination is a huge barrier to self-management. Delegate and prioritise #EULAR2024 Andrea Marques @RheumNow https://t.co/SbQgOMwqL0
Links:
Dr. Antoni Chan @synovialjoints ( View Tweet )
1 year 10 months ago
Steroids are often started before pts see a rheumatologist
This associates with long-term low-dose steroid use
Need better collaboration between referrers and rheum to reduce this avoidable steroid burden
POS0137 @RheumNow #EULAR2024
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 10 months ago
#EULAR2024 POS0436 Another benefit of T2T to achieve remission by using less NSAIDs, lower GC, earlier use of SFZ, HCQ and TNF-i = shorter Time to Pregnancy from conception in #RA women (median 84 days) vs without pre-counselling & T2T (196 days) @RheumNow https://t.co/2ZpDLmPVt0
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 10 months ago
Data form TARA trial Taper in RA remission
Flare free survival at 2 yrs 35%
Risk of flare is similar in ACPA+ & ACPA- RA
Risk of flare is similar if taper TNFi first or csDMARD first
@RheumNow #EULAR2024 POS0405 https://t.co/89gAglHUcw
Aurelie Najm @AurelieRheumo ( View Tweet )
1 year 10 months ago
POS0509 looks at time to diagnosis and #comorbidity burden in #axSpa
Retrospective study in French THIN database
Diagnostic delay remains common
Increased number of MSK & non-MSK manifestations & #comorbidities over time vs 1st presentation of back pain
@RheumNow #EULAR2024
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 10 months ago
´The health care professionals ànd caregivers also need to be well in order to deliver care for patients’ Andrea Marques speaking at the self-management session at #EULAR2024 @RheumNow https://t.co/BrEHPTbbti
Dr. Antoni Chan @synovialjoints ( View Tweet )
1 year 10 months ago
Autoantibody measures in 5 scandinavian cohorts 6900+ RA pts
Four cit-peptides w/ high frequency
Cit Fibb36-52 (51%) Cit Fibb60-74-Cit3 (59%) Cit Fil307-324 (54%) Cit Vim60-75-Cit1 (63%)
Capture 97% of IgG CCP2+ & 22% IgG CCP2-
42% of all pts + IgG anti-Carb or Acet peptides… https://t.co/yYr6AzgipM https://t.co/6dP6Sgi3yB
Links:
Aurelie Najm @AurelieRheumo ( View Tweet )
1 year 10 months ago
#EULAR2024
@AilsaBosworth1 highlights the programmes available for pts diagnosed with #RA via the @NRAS_UK platform
SMILE-RA and RightStart are great resources for self-management, can highly recommend to all clinicians!
@RheumNow https://t.co/SgAMKkcycE
Links:
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 10 months ago
Just some of the barriers to supporting patients in self-management.
Important to note the array of factors at play, some easier to address than others but all should be acknowledged to tailor individual self-management guidance.
@RheumNow @ElenaNikiUK #EULAR2024 https://t.co/GJM35l275V
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 10 months ago
